nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenac—ASIC1—Ion channel transport—GABRA2—conduct disorder	0.0551	0.0562	CbGpPWpGaD
Diclofenac—UGT2B7—Estrogen metabolism—COMT—conduct disorder	0.0322	0.0328	CbGpPWpGaD
Diclofenac—CXCR1—GPCRs, Other—DRD4—conduct disorder	0.0291	0.0296	CbGpPWpGaD
Diclofenac—UGT1A1—Estrogen metabolism—COMT—conduct disorder	0.0262	0.0266	CbGpPWpGaD
Diclofenac—CXCL8—Glucocorticoid receptor regulatory network—CGA—conduct disorder	0.0254	0.0259	CbGpPWpGaD
Diclofenac—CXCR1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0193	0.0197	CbGpPWpGaD
Diclofenac—ASIC1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.0192	0.0195	CbGpPWpGaD
Diclofenac—CXCR1—GPCRs, Other—HTR2A—conduct disorder	0.019	0.0193	CbGpPWpGaD
Diclofenac—KCNQ2—Neuronal System—GABRA2—conduct disorder	0.0164	0.0167	CbGpPWpGaD
Diclofenac—KCNQ3—Neuronal System—GABRA2—conduct disorder	0.0164	0.0167	CbGpPWpGaD
Diclofenac—CYP1A2—Methylation—COMT—conduct disorder	0.0153	0.0156	CbGpPWpGaD
Diclofenac—CYP1A1—Estrogen metabolism—COMT—conduct disorder	0.015	0.0153	CbGpPWpGaD
Diclofenac—CXCR1—GPCR ligand binding—CGA—conduct disorder	0.0147	0.015	CbGpPWpGaD
Diclofenac—CXCR1—G alpha (i) signalling events—DRD4—conduct disorder	0.0136	0.0139	CbGpPWpGaD
Diclofenac—CXCR1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.0126	0.0129	CbGpPWpGaD
Diclofenac—CXCR1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.0108	0.011	CbGpPWpGaD
Diclofenac—CYP1A1—Melatonin metabolism and effects—MAOA—conduct disorder	0.0102	0.0104	CbGpPWpGaD
Diclofenac—CYP2C18—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0102	0.0104	CbGpPWpGaD
Diclofenac—CYP1A1—Oxidative Stress—MAOA—conduct disorder	0.00991	0.0101	CbGpPWpGaD
Diclofenac—CYP1A2—Estrogen metabolism—COMT—conduct disorder	0.00958	0.00976	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00937	0.00954	CbGpPWpGaD
Diclofenac—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—EP300—conduct disorder	0.00931	0.00948	CbGpPWpGaD
Diclofenac—CXCL8—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.00906	0.00923	CbGpPWpGaD
Diclofenac—UGT2B7—Phase II conjugation—COMT—conduct disorder	0.00904	0.00921	CbGpPWpGaD
Diclofenac—CXCL8—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00872	0.00888	CbGpPWpGaD
Diclofenac—CYP2C19—Melatonin metabolism and effects—MAOA—conduct disorder	0.00834	0.00849	CbGpPWpGaD
Diclofenac—CXCR1—GPCR downstream signaling—CGA—conduct disorder	0.00831	0.00846	CbGpPWpGaD
Diclofenac—CXCR1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00824	0.00839	CbGpPWpGaD
Diclofenac—CXCR1—GPCR ligand binding—DRD4—conduct disorder	0.00824	0.00839	CbGpPWpGaD
Diclofenac—UGT2B7—NRF2 pathway—SLC6A4—conduct disorder	0.00796	0.00811	CbGpPWpGaD
Diclofenac—KCNQ2—Neuronal System—COMT—conduct disorder	0.00789	0.00804	CbGpPWpGaD
Diclofenac—KCNQ3—Neuronal System—COMT—conduct disorder	0.00789	0.00804	CbGpPWpGaD
Diclofenac—SLCO1C1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00785	0.008	CbGpPWpGaD
Diclofenac—KCNQ2—Neuronal System—MAOA—conduct disorder	0.00783	0.00798	CbGpPWpGaD
Diclofenac—KCNQ3—Neuronal System—MAOA—conduct disorder	0.00783	0.00798	CbGpPWpGaD
Diclofenac—CXCR1—Signaling by GPCR—CGA—conduct disorder	0.00755	0.00769	CbGpPWpGaD
Diclofenac—ABCC4—NRF2 pathway—SLC6A4—conduct disorder	0.00748	0.00762	CbGpPWpGaD
Diclofenac—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.00739	0.00753	CbGpPWpGaD
Diclofenac—UGT1A1—Phase II conjugation—COMT—conduct disorder	0.00735	0.00749	CbGpPWpGaD
Diclofenac—CXCR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00706	0.00719	CbGpPWpGaD
Diclofenac—CYP2C18—FOXA1 transcription factor network—EP300—conduct disorder	0.00694	0.00707	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00688	0.007	CbGpPWpGaD
Diclofenac—CXCL8—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00682	0.00695	CbGpPWpGaD
Diclofenac—CXCL8—GPCR ligand binding—CGA—conduct disorder	0.00664	0.00676	CbGpPWpGaD
Diclofenac—PTGS1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00655	0.00667	CbGpPWpGaD
Diclofenac—CYP1A2—Melatonin metabolism and effects—MAOA—conduct disorder	0.00649	0.00662	CbGpPWpGaD
Diclofenac—UGT1A1—NRF2 pathway—SLC6A4—conduct disorder	0.00647	0.00659	CbGpPWpGaD
Diclofenac—CXCL8—ATF-2 transcription factor network—EP300—conduct disorder	0.00641	0.00653	CbGpPWpGaD
Diclofenac—CXCL8—G alpha (i) signalling events—DRD4—conduct disorder	0.00614	0.00625	CbGpPWpGaD
Diclofenac—CXCL8—AP-1 transcription factor network—EP300—conduct disorder	0.00559	0.0057	CbGpPWpGaD
Diclofenac—CXCL8—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00556	0.00566	CbGpPWpGaD
Diclofenac—CYP2C18—Biological oxidations—COMT—conduct disorder	0.00544	0.00554	CbGpPWpGaD
Diclofenac—CYP2C18—Biological oxidations—MAOA—conduct disorder	0.0054	0.0055	CbGpPWpGaD
Diclofenac—CXCR1—GPCR ligand binding—HTR2A—conduct disorder	0.00537	0.00547	CbGpPWpGaD
Diclofenac—CYP2C18—Metapathway biotransformation—COMT—conduct disorder	0.00536	0.00546	CbGpPWpGaD
Diclofenac—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.0053	0.00539	CbGpPWpGaD
Diclofenac—UGT2B7—Biological oxidations—COMT—conduct disorder	0.00529	0.00539	CbGpPWpGaD
Diclofenac—UGT2B7—Biological oxidations—MAOA—conduct disorder	0.00525	0.00535	CbGpPWpGaD
Diclofenac—UGT2B7—Metapathway biotransformation—COMT—conduct disorder	0.00522	0.00532	CbGpPWpGaD
Diclofenac—SLC22A11—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00516	0.00526	CbGpPWpGaD
Diclofenac—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—conduct disorder	0.00502	0.00512	CbGpPWpGaD
Diclofenac—CYP2B6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.005	0.00509	CbGpPWpGaD
Diclofenac—CXCL8—Glucocorticoid receptor regulatory network—EP300—conduct disorder	0.00493	0.00502	CbGpPWpGaD
Diclofenac—CYP2E1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0049	0.00499	CbGpPWpGaD
Diclofenac—CXCL8—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00488	0.00497	CbGpPWpGaD
Diclofenac—CXCL8—Metabolism of proteins—CGA—conduct disorder	0.00467	0.00476	CbGpPWpGaD
Diclofenac—CXCR1—GPCR downstream signaling—DRD4—conduct disorder	0.00465	0.00474	CbGpPWpGaD
Diclofenac—CYP1A1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00462	0.0047	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—CGA—conduct disorder	0.00446	0.00454	CbGpPWpGaD
Diclofenac—UGT1A1—Biological oxidations—COMT—conduct disorder	0.0043	0.00438	CbGpPWpGaD
Diclofenac—UGT1A1—Biological oxidations—MAOA—conduct disorder	0.00427	0.00435	CbGpPWpGaD
Diclofenac—UGT1A1—Metapathway biotransformation—COMT—conduct disorder	0.00424	0.00432	CbGpPWpGaD
Diclofenac—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00423	0.00431	CbGpPWpGaD
Diclofenac—CXCR1—Signaling by GPCR—DRD4—conduct disorder	0.00423	0.0043	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism—CGA—conduct disorder	0.00417	0.00425	CbGpPWpGaD
Diclofenac—SLC22A8—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00394	0.00401	CbGpPWpGaD
Diclofenac—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00378	0.00385	CbGpPWpGaD
Diclofenac—ABCC4—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00377	0.00384	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—CGA—conduct disorder	0.00375	0.00382	CbGpPWpGaD
Diclofenac—CXCL8—GPCR ligand binding—DRD4—conduct disorder	0.00372	0.00379	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—WASF1—conduct disorder	0.00357	0.00364	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00353	0.00359	CbGpPWpGaD
Diclofenac—PTGS1—Biological oxidations—COMT—conduct disorder	0.0035	0.00357	CbGpPWpGaD
Diclofenac—PTGS1—Biological oxidations—MAOA—conduct disorder	0.00348	0.00354	CbGpPWpGaD
Diclofenac—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00344	0.00351	CbGpPWpGaD
Diclofenac—PTGS2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00343	0.00349	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—CGA—conduct disorder	0.00341	0.00347	CbGpPWpGaD
Diclofenac—SLC22A6—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00329	0.00335	CbGpPWpGaD
Diclofenac—CXCL8—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00318	0.00324	CbGpPWpGaD
Diclofenac—ABCC1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00315	0.0032	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—CGA—conduct disorder	0.00306	0.00312	CbGpPWpGaD
Diclofenac—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00304	0.0031	CbGpPWpGaD
Diclofenac—CYP1A1—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00304	0.0031	CbGpPWpGaD
Diclofenac—CXCR1—GPCR downstream signaling—HTR2A—conduct disorder	0.00304	0.00309	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—CGA—conduct disorder	0.003	0.00306	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00298	0.00304	CbGpPWpGaD
Diclofenac—CXCL8—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00295	0.003	CbGpPWpGaD
Diclofenac—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00294	0.003	CbGpPWpGaD
Diclofenac—CXCR1—Signaling by GPCR—HTR2A—conduct disorder	0.00276	0.00281	CbGpPWpGaD
Diclofenac—CYP1A2—Phase II conjugation—COMT—conduct disorder	0.00269	0.00274	CbGpPWpGaD
Diclofenac—CYP2B6—Biological oxidations—COMT—conduct disorder	0.00267	0.00272	CbGpPWpGaD
Diclofenac—CYP2B6—Biological oxidations—MAOA—conduct disorder	0.00266	0.0027	CbGpPWpGaD
Diclofenac—CYP2B6—Metapathway biotransformation—COMT—conduct disorder	0.00264	0.00269	CbGpPWpGaD
Diclofenac—CYP2E1—Biological oxidations—COMT—conduct disorder	0.00262	0.00267	CbGpPWpGaD
Diclofenac—CYP2E1—Biological oxidations—MAOA—conduct disorder	0.0026	0.00265	CbGpPWpGaD
Diclofenac—CYP2E1—Metapathway biotransformation—COMT—conduct disorder	0.00258	0.00263	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—DRD4—conduct disorder	0.0025	0.00254	CbGpPWpGaD
Diclofenac—CYP1A1—Biological oxidations—COMT—conduct disorder	0.00247	0.00252	CbGpPWpGaD
Diclofenac—CYP1A1—Biological oxidations—MAOA—conduct disorder	0.00245	0.0025	CbGpPWpGaD
Diclofenac—CYP1A1—Metapathway biotransformation—COMT—conduct disorder	0.00244	0.00248	CbGpPWpGaD
Diclofenac—CXCL8—GPCR ligand binding—HTR2A—conduct disorder	0.00243	0.00247	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—WASF1—conduct disorder	0.0024	0.00245	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00237	0.00241	CbGpPWpGaD
Diclofenac—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00227	0.00231	CbGpPWpGaD
Diclofenac—CYP2C8—Biological oxidations—COMT—conduct disorder	0.00226	0.00231	CbGpPWpGaD
Diclofenac—CYP2C8—Biological oxidations—MAOA—conduct disorder	0.00225	0.00229	CbGpPWpGaD
Diclofenac—CYP2C8—Metapathway biotransformation—COMT—conduct disorder	0.00223	0.00227	CbGpPWpGaD
Diclofenac—ASIC1—brain—conduct disorder	0.00219	0.121	CbGeAlD
Diclofenac—KCNQ2—Developmental Biology—EP300—conduct disorder	0.00214	0.00218	CbGpPWpGaD
Diclofenac—KCNQ3—Developmental Biology—EP300—conduct disorder	0.00214	0.00218	CbGpPWpGaD
Diclofenac—PTGS2—C-MYB transcription factor network—EP300—conduct disorder	0.00212	0.00216	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.0021	0.00214	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—DRD4—conduct disorder	0.0021	0.00214	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—CGA—conduct disorder	0.00206	0.0021	CbGpPWpGaD
Diclofenac—CYP2C19—Biological oxidations—COMT—conduct disorder	0.00202	0.00206	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—CGA—conduct disorder	0.00201	0.00205	CbGpPWpGaD
Diclofenac—CYP2C19—Biological oxidations—MAOA—conduct disorder	0.00201	0.00204	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—CGA—conduct disorder	0.002	0.00204	CbGpPWpGaD
Diclofenac—CYP2C19—Metapathway biotransformation—COMT—conduct disorder	0.00199	0.00203	CbGpPWpGaD
Diclofenac—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00194	0.00198	CbGpPWpGaD
Diclofenac—CYP1A2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00194	0.00198	CbGpPWpGaD
Diclofenac—CXCL8—Cellular responses to stress—EP300—conduct disorder	0.00193	0.00197	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00193	0.00196	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00191	0.00195	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—DRD4—conduct disorder	0.00191	0.00194	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism—COMT—conduct disorder	0.00188	0.00192	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism—MAOA—conduct disorder	0.00187	0.0019	CbGpPWpGaD
Diclofenac—CYP2C9—Biological oxidations—COMT—conduct disorder	0.00184	0.00188	CbGpPWpGaD
Diclofenac—CYP2C9—Biological oxidations—MAOA—conduct disorder	0.00183	0.00186	CbGpPWpGaD
Diclofenac—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.00182	0.00185	CbGpPWpGaD
Diclofenac—CYP2C9—Metapathway biotransformation—COMT—conduct disorder	0.00182	0.00185	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00181	0.00185	CbGpPWpGaD
Diclofenac—KCNQ3—brain—conduct disorder	0.00175	0.0958	CbGeAlD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00172	0.00175	CbGpPWpGaD
Diclofenac—ALB—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00171	0.00174	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—DRD4—conduct disorder	0.00168	0.00171	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—HTR2A—conduct disorder	0.00163	0.00166	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—CGA—conduct disorder	0.00163	0.00166	CbGpPWpGaD
Diclofenac—SCN4A—Developmental Biology—EP300—conduct disorder	0.00162	0.00165	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—WASF1—conduct disorder	0.00161	0.00164	CbGpPWpGaD
Diclofenac—KCNQ2—brain—conduct disorder	0.00161	0.0882	CbGeAlD
Diclofenac—CYP1A2—Biological oxidations—COMT—conduct disorder	0.00157	0.0016	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—CGA—conduct disorder	0.00157	0.0016	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00157	0.0016	CbGpPWpGaD
Diclofenac—CYP1A2—Biological oxidations—MAOA—conduct disorder	0.00156	0.00159	CbGpPWpGaD
Diclofenac—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	0.00155	0.00158	CbGpPWpGaD
Diclofenac—CYP1A1—PPARA activates gene expression—EP300—conduct disorder	0.00151	0.00154	CbGpPWpGaD
Diclofenac—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.0015	0.00152	CbGpPWpGaD
Diclofenac—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—conduct disorder	0.00148	0.00151	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—COMT—conduct disorder	0.00138	0.00141	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—MAOA—conduct disorder	0.00137	0.0014	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—HTR2A—conduct disorder	0.00137	0.0014	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00134	0.00136	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00133	0.00136	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—CGA—conduct disorder	0.00133	0.00135	CbGpPWpGaD
Diclofenac—PLA2G2A—brain—conduct disorder	0.00132	0.0726	CbGeAlD
Diclofenac—CXCL8—brain—conduct disorder	0.00131	0.0719	CbGeAlD
Diclofenac—CXCL8—Signaling by GPCR—HTR2A—conduct disorder	0.00124	0.00127	CbGpPWpGaD
Diclofenac—CYP3A4—Biological oxidations—COMT—conduct disorder	0.00122	0.00124	CbGpPWpGaD
Diclofenac—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.00121	0.00123	CbGpPWpGaD
Diclofenac—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.0012	0.00122	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—DRD4—conduct disorder	0.00113	0.00115	CbGpPWpGaD
Diclofenac—SLCO1C1—brain—conduct disorder	0.00112	0.0613	CbGeAlD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.0011	0.00112	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—HTR2A—conduct disorder	0.0011	0.00112	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—CGA—conduct disorder	0.00105	0.00107	CbGpPWpGaD
Diclofenac—SCN4A—brain—conduct disorder	0.00103	0.0564	CbGeAlD
Diclofenac—SLC22A6—brain—conduct disorder	0.00102	0.0561	CbGeAlD
Diclofenac—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—conduct disorder	0.00102	0.00104	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—CGA—conduct disorder	0.00101	0.00103	CbGpPWpGaD
Diclofenac—TTR—brain—conduct disorder	0.000999	0.0548	CbGeAlD
Diclofenac—CYP2E1—Metabolism—CGA—conduct disorder	0.000992	0.00101	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—CGA—conduct disorder	0.000936	0.000953	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—COMT—conduct disorder	0.00093	0.000947	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—MAOA—conduct disorder	0.000924	0.000941	CbGpPWpGaD
Diclofenac—ALOX5—brain—conduct disorder	0.000905	0.0497	CbGeAlD
Diclofenac—UGT2B7—Metabolism—COMT—conduct disorder	0.000905	0.000922	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—EP300—conduct disorder	0.0009	0.000916	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—MAOA—conduct disorder	0.000898	0.000915	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—EP300—conduct disorder	0.000863	0.000879	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—CGA—conduct disorder	0.000858	0.000874	CbGpPWpGaD
Diclofenac—ALB—Metabolism—CGA—conduct disorder	0.000853	0.000869	CbGpPWpGaD
Diclofenac—TTR—Disease—EP300—conduct disorder	0.000829	0.000845	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism—EP300—conduct disorder	0.000808	0.000823	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000778	0.000792	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—CGA—conduct disorder	0.000766	0.00078	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CGA—conduct disorder	0.000747	0.000761	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—COMT—conduct disorder	0.000735	0.000749	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—HTR2A—conduct disorder	0.000735	0.000749	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—MAOA—conduct disorder	0.00073	0.000744	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—COMT—conduct disorder	0.000709	0.000722	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—MAOA—conduct disorder	0.000704	0.000717	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CGA—conduct disorder	0.000698	0.000711	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000683	0.000695	CbGpPWpGaD
Diclofenac—ALB—brain—conduct disorder	0.000637	0.035	CbGeAlD
Diclofenac—ABCC4—brain—conduct disorder	0.000617	0.0339	CbGeAlD
Diclofenac—SLC22A8—brain—conduct disorder	0.000612	0.0336	CbGeAlD
Diclofenac—PTGS1—Metabolism—COMT—conduct disorder	0.000599	0.00061	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CGA—conduct disorder	0.000596	0.000608	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—MAOA—conduct disorder	0.000595	0.000606	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—EP300—conduct disorder	0.000593	0.000604	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—EP300—conduct disorder	0.000581	0.000591	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000577	0.000588	CbGpPWpGaD
Diclofenac—ABCC1—brain—conduct disorder	0.000526	0.0289	CbGeAlD
Diclofenac—PTGS2—Metabolism—COMT—conduct disorder	0.000476	0.000485	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—MAOA—conduct disorder	0.000472	0.000481	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CGA—conduct disorder	0.00046	0.000469	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000458	0.000467	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—COMT—conduct disorder	0.000457	0.000466	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—MAOA—conduct disorder	0.000454	0.000463	CbGpPWpGaD
Diclofenac—CYP2C8—brain—conduct disorder	0.000448	0.0246	CbGeAlD
Diclofenac—CYP2E1—Metabolism—COMT—conduct disorder	0.000448	0.000456	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—MAOA—conduct disorder	0.000445	0.000453	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—COMT—conduct disorder	0.000422	0.00043	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—MAOA—conduct disorder	0.000419	0.000427	CbGpPWpGaD
Diclofenac—CYP1A1—brain—conduct disorder	0.000413	0.0227	CbGeAlD
Diclofenac—ALB—Hemostasis—EP300—conduct disorder	0.000407	0.000415	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000407	0.000414	CbGpPWpGaD
Diclofenac—CYP2B6—brain—conduct disorder	0.000402	0.0221	CbGeAlD
Diclofenac—CYP2C18—Metabolism—EP300—conduct disorder	0.000399	0.000406	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—EP300—conduct disorder	0.000389	0.000397	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—EP300—conduct disorder	0.000388	0.000395	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—COMT—conduct disorder	0.000387	0.000394	CbGpPWpGaD
Diclofenac—ALB—Metabolism—COMT—conduct disorder	0.000385	0.000392	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—MAOA—conduct disorder	0.000384	0.000392	CbGpPWpGaD
Diclofenac—ALB—Metabolism—MAOA—conduct disorder	0.000382	0.000389	CbGpPWpGaD
Diclofenac—CYP2E1—brain—conduct disorder	0.000377	0.0207	CbGeAlD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000373	0.00038	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000371	0.000378	CbGpPWpGaD
Diclofenac—PTGS1—brain—conduct disorder	0.000363	0.0199	CbGeAlD
Diclofenac—ABCC1—Disease—EP300—conduct disorder	0.000363	0.00037	CbGpPWpGaD
Diclofenac—PTGS2—brain—conduct disorder	0.000347	0.0191	CbGeAlD
Diclofenac—CYP2C19—Metabolism—COMT—conduct disorder	0.000346	0.000352	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—MAOA—conduct disorder	0.000343	0.000349	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—COMT—conduct disorder	0.000337	0.000344	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—MAOA—conduct disorder	0.000335	0.000341	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000333	0.000339	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—EP300—conduct disorder	0.000315	0.000321	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—COMT—conduct disorder	0.000315	0.000321	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—MAOA—conduct disorder	0.000313	0.000319	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—EP300—conduct disorder	0.000304	0.00031	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000303	0.000309	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—COMT—conduct disorder	0.000269	0.000274	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—MAOA—conduct disorder	0.000267	0.000272	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000259	0.000264	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—EP300—conduct disorder	0.000257	0.000262	CbGpPWpGaD
Diclofenac—PTGS2—Disease—EP300—conduct disorder	0.000244	0.000248	CbGpPWpGaD
Diclofenac—ABCB1—brain—conduct disorder	0.000215	0.0118	CbGeAlD
Diclofenac—CYP3A4—Metabolism—COMT—conduct disorder	0.000208	0.000212	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—MAOA—conduct disorder	0.000206	0.00021	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—EP300—conduct disorder	0.000204	0.000208	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—EP300—conduct disorder	0.000196	0.0002	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—EP300—conduct disorder	0.000192	0.000196	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—EP300—conduct disorder	0.000181	0.000184	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—EP300—conduct disorder	0.000166	0.000169	CbGpPWpGaD
Diclofenac—ALB—Metabolism—EP300—conduct disorder	0.000165	0.000168	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—EP300—conduct disorder	0.000148	0.000151	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—EP300—conduct disorder	0.000145	0.000147	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—EP300—conduct disorder	0.000135	0.000138	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—EP300—conduct disorder	0.000115	0.000118	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—EP300—conduct disorder	8.91e-05	9.08e-05	CbGpPWpGaD
